ClinicalTrials.Veeva

Menu

Different Modalities in Reducing Airborne Particulate Concentrations During AGP for Health Volunteers

Rush logo

Rush

Status

Completed

Conditions

Transmission, Patient-Professional

Treatments

Device: Filter
Device: Scavenger face tent

Study type

Interventional

Funder types

Other

Identifiers

NCT04681599
AGP aerosol 002

Details and patient eligibility

About

Several clinical procedures have been described as aerosol generating procedure (AGP), including nebulization, high-flow nasal cannula oxygen therapy, noninvasive ventilation, and bronchial hygiene treatment, etc. However, the understanding on the transmission risk of these treatments is still unclear, particularly the methods to reduce the airborne particulate concentrations during these treatments are still lacking. This study is aimed to compare different modalities in reducing airborne particulate concentrations during these aerosol generating procedures, in order to find the most effective method to reduce particle concentrations, ultimately to decrease the transmission risk and protect health care providers.

Enrollment

18 patients

Sex

All

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

• Ages 18-65, Male or Female

Exclusion criteria

  • Chronic lung disease, including asthma, COPD, etc.
  • Upper airway anatomical abnormities
  • Pregnancy
  • Uncontrolled Diabetes, hypertension, or untreated thyroid disease
  • Has any of the following symptoms in the last 21 days: sore throat, cough, chills, body aches for unknown reasons, shortness of breath for unknown reasons, loss of smell, loss of taste, fever at or greater than 100 degrees Fahrenheit.
  • COVID-19 test positive within 21 days.

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

18 participants in 5 patient groups

Nebulization without filter or scavenger
No Intervention group
Description:
Subject will use a standard nebulizer
Nebulization with a filter or scavenger
Experimental group
Description:
Subject will use a nebulizer with a filter placed at the other end of nebulizer mouthpice or a scavenger outside the nebulizer mask
Treatment:
Device: Scavenger face tent
Device: Filter
High-flow nasal cannula
No Intervention group
Description:
Subject will use high-flow nasal cannula at 40 L/min
High-flow nasal cannula with a scavenger face tent
Experimental group
Description:
Subject will use high-flow nasal cannula at 40 L/min, with a scavenger face tent
Treatment:
Device: Scavenger face tent
High-flow nasal cannula with a surgical mask
Active Comparator group
Description:
Subject will use high-flow nasal cannula at 40 L/min, with a surgical mask over nasal cannula
Treatment:
Device: Filter

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems